BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1193723)

  • 1. In vivo and in vitro stimulation of mouse spleen leukocytes by BL-20803, a low-molecular-weight interferon inducer.
    Siminoff P
    Infect Immun; 1975 Nov; 12(5):1051-7. PubMed ID: 1193723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of interferon production in mice and in mouse spleen leukocytes by analogues of BL-20803.
    Siminoff P; Crenshaw RR
    Antimicrob Agents Chemother; 1977 Mar; 11(3):571-3. PubMed ID: 856006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target cells for interferon induction by BL-20803.
    Siminoff P
    J Infect Dis; 1976 Jun; 133 Suppl():A37-42. PubMed ID: 932505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine induction in mice by the immunomodulator imiquimod.
    Reiter MJ; Testerman TL; Miller RL; Weeks CE; Tomai MA
    J Leukoc Biol; 1994 Feb; 55(2):234-40. PubMed ID: 7507969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines).
    Degré M; Gláz ET
    Acta Pathol Microbiol Scand B; 1977 Jun; 85(3):189-94. PubMed ID: 888701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferonogenic activity of amixin analogs and diphenyl derivatives].
    Shaĭ DS; Zholobak NM; Liakhov SA; Mal'tsev HV; Fernandes de Rivas SO; Lytvynova LO; Andronati SA; Spivak MIa
    Mikrobiol Z; 2007; 69(5):59-64. PubMed ID: 18217355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferonogenic activity of immobilized ribopolynucleotides in vitro].
    Zholobak NM; Mandzhos AP; Verevka SV; Povodzinskiĭ VM; Karpov AV
    Ukr Biokhim Zh (1999); 2003; 75(6):106-10. PubMed ID: 15143526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tilorone hydrochloride: an oral interferon-inducing agent.
    Stringfellow DA; Glasgow LA
    Antimicrob Agents Chemother; 1972 Aug; 2(2):73-8. PubMed ID: 4670490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs.
    Gláz ET; Tálas M
    Arch Virol; 1975; 48(4):375-84. PubMed ID: 1200845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of glucose transport of Ehrlich ascites tumour cell by interferon inducers.
    Fung KP; Ng SW; Ha DK; Choy YM
    Chemotherapy; 1986; 32(5):458-63. PubMed ID: 2428563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of interferon production in vitro: a property of tilorone-poly rL:rC/DEAE-Dextran.
    Groelke JW; Camyre KP; Mayer GD
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1044-7. PubMed ID: 165541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by muramyldipeptides of the activities of early-type inducers of interferon.
    Ikeda S; Matsuda Y; Nishimura C
    Antiviral Res; 1985 Dec; 5(6):345-53. PubMed ID: 2418780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
    Kern ER; Hamilton JR; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon with low molecular weight compounds: fluorenone esters, ethers (tilorone), and pyrimidinones.
    Stringfellow DA
    Methods Enzymol; 1981; 78(Pt A):262-84. PubMed ID: 6173601
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice: natural killer cell activity in cultured spleen leukocytes concomitant with T-cell-dependent immune interferon production.
    Welsh RM; Doe WF
    Infect Immun; 1980 Nov; 30(2):473-83. PubMed ID: 6160108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced NK cell activity in mice injected with interferon and interferon inducers.
    Gidlund M; Orn A; Wigzell H; Senik A; Gresser I
    Nature; 1978 Jun; 273(5665):759-61. PubMed ID: 566386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of interferon production from the enteral administration of inducers].
    Grigorian SS; Ershov FI; Poverennyĭ AM; Popov GA; Podgorodnichenko VK
    Vopr Virusol; 1988; 33(1):67-70. PubMed ID: 2453100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The interferonogenic properties of yeast RNA-tilorone complexes in a cell culture].
    Karpov AV; Zholobak NM
    Antibiot Khimioter; 1995 May; 40(5):20-3. PubMed ID: 8534174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon inducers and purified mouse interferon on the susceptibility of mice to infection with Listeria monocytogenes.
    Grappel SF; Polansky MJ; Actor P
    Adv Exp Med Biol; 1983; 162():227-33. PubMed ID: 6191531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.